Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al.

Scott D. Grosse

doi:10.1160/TH11-09-0666

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2012; 107(01): 192-193
DOI: 10.1160/TH11-09-0666

Author Correspondence

Schattauer GmbH

Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al.

Authors

Scott D. Grosse

¹Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Abstract

Full Text

References

References
1 Mahan CE, Holdsworth MT, Welch SM. et al. Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event. Thromb Haemost 2011; 106: 405-415.
2 Grosse SD.. Economic evaluations of newborn screening interventions. In: Ungar WJ. (ed). Economic Evaluation in Child Health. Oxford University Press; 2009: 113-132.
3 Heit JA, O’Fallon WM, Petterson TM. et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-1248.
4 Spencer FA, Emery C, Lessard D. et al. The Worcester Venous Thromboembolism Study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21: 722-727.
5 White RH.. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8.
6 Braekkan SK, Mathiesen EB, Njølstad I. et al. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost 2008; 06: 1851-1857.
7 Naess IA, Christiansen SC, Romundstad P. et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 05: 692-699.
8 Cushman M, Tsai AW, White RH. et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
9 Heit JA, Mohr DN, Silverstein MD. et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-768.
10 Spencer FA, Gore JM, Lessard D. et al. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med 2008; 168: 425-430.
11 Prandoni P, Lensing AW, Cogo A. et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
12 Douketis JD, Gu CS, Schulman S. et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147: 766-774.
13 Centers for Disease Control and Prevention. National Center on Birth Defects and Developmental Disabilities Strategic Plan 2011-2015. Available at: http://www.cdc.gov/NCBDDD/AboutUs/documents/NCBDDD_StrategicPlan_2–10–11.pdf Accessed September 12, 2011.
14 Raskob G, Silverstein R, Bratzler D. et al. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 2010; 38: S502-S509.
15 Beckman MG, Grosse SD, Kenney KM. et al. Developing surveillance activities for deep vein thrombosis and pulmonary embolism. Am J Prev Med 2011; 41: S428-S434.
16 White RH, Zhou H, Murin S. et al. Effect of ethnicity and gender on the incidence of venous throm-boembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
17 Stein PD, Kayali F, Olson RE. et al. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med. 2004; 116: 435-442.
18 James AH, Jamison MG, Brancazio LR. et al. Venous thromboembolism during pregnancy and the post-partum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194: 1311-1315.
19 Heit JA, Beckman MG, Bockenstedt PL. et al. Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol 2010; 85: 467-471.
20 Sørensen HT, Riis AH, Diaz LJ. et al. Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost 2011; 09: 320-324.
21 Severinsen MT, Johnsen SP, Tjønneland A. et al. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med 2010; 21: 268-272.
22 Holst AG, Jensen G, Prescott E.. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010; 121: 1896-1903.
23 U.S. Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. 2008
24 Beckman MG, Hooper WC, Critchley SE. et al. Venous thromboembolism: a public health concern. Am J Prev Med 2010; 38: S495-S501.
25 Spencer FA, Lessard D, Emery C. et al. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167: 1471-1475.
26 Maynard GA, Morris TA, Jenkins IH. et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med 2010; 05: 10-18.
27 Kucher N, Koo S, Quiroz R. et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352: 969-977.
28 Novis SJ, Havelka GE, Ostrowski D. et al. Prevention of thromboembolic events in surgical patients through the creation and implementation of a computerized risk assessment program. J Vasc Surg. 2010; 51: 648-654.
29 Cronin M, Hill T, Reich DA. et al. Implementation of a multidisciplinary, pharmacy-led, thromboprophylaxis program in total-joint arthroplasty patients. Am J Health Syst Pharm 2009; 66: 171-175.
30 Mahan CE, Spyropoulos AC.. Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient. Hosp Pract (Minneap) 2010; 38: 97-108.
31 Amin A, Hussein M, Battleman D. et al. Appropriate VTE prophylaxis is associated with lower direct medical costs. Hosp Pract (Minneap) 2010; 38: 130-137.
32 Biffl WL, Beno M, Goodman P. et al. „Leaning” the process of venous thromboembolism prophylaxis. Jt Comm J Qual Patient Saf. 2011; 37: 99-109.
33 Amin AN, Lin J, Johnson BH. et al. Clinical and economic outcomes with appropriate or partial prophylaxis. Thromb Res. 2010; 125: 513-517.